Medtronic plc Files 8-K on Financials

Ticker: MDT · Form: 8-K · Filed: 2024-05-23T00:00:00.000Z

Sentiment: neutral

Topics: financial-condition, results-of-operations, sec-filing

TL;DR

Medtronic dropped an 8-K on May 23rd, check the financials.

AI Summary

On May 23, 2024, Medtronic plc filed an 8-K report detailing its financial condition and results of operations. The filing includes various exhibits related to its financial statements and other relevant information. Medtronic plc, headquartered in Dublin, Ireland, is a significant player in the electromedical and electrotherapeutic apparatus industry.

Why It Matters

This 8-K filing provides investors and stakeholders with an update on Medtronic's financial condition and operational results, which can influence investment decisions and market perception.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of financial information and does not indicate any unusual risks or events.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by Medtronic plc?

The primary purpose of this 8-K filing is to report on Medtronic plc's Results of Operations and Financial Condition, as well as to provide Financial Statements and Exhibits.

When was this 8-K filing submitted to the SEC?

This 8-K filing was submitted to the SEC on May 23, 2024.

What is Medtronic plc's Standard Industrial Classification (SIC) code?

Medtronic plc's SIC code is 3845, which corresponds to Electromedical & Electrotherapeutic Apparatus.

Where is Medtronic plc's business address listed in the filing?

Medtronic plc's business address is listed as 20 On Hatch, Lower Hatch Street, Dublin, L2, Ireland.

Does the filing mention any specific financial figures or debt instruments?

The filing lists various senior note series (e.g., Senior Notes 2019 Due 2025, Senior Notes 2020 Due 2025, Senior Notes Due 2025, etc.) with associated dates, but does not provide specific dollar amounts for these instruments in the provided text.

From the Filing

0001613103-24-000058.txt : 20240523 0001613103-24-000058.hdr.sgml : 20240523 20240523064745 ACCESSION NUMBER: 0001613103-24-000058 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240523 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240523 DATE AS OF CHANGE: 20240523 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Medtronic plc CENTRAL INDEX KEY: 0001613103 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 FISCAL YEAR END: 0426 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36820 FILM NUMBER: 24975165 BUSINESS ADDRESS: STREET 1: 20 ON HATCH, LOWER HATCH STREET CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: 01135314381700 MAIL ADDRESS: STREET 1: 20 ON HATCH, LOWER HATCH STREET CITY: DUBLIN STATE: L2 ZIP: 2 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Ltd DATE OF NAME CHANGE: 20150112 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Holdings Ltd DATE OF NAME CHANGE: 20140711 FORMER COMPANY: FORMER CONFORMED NAME: Kalani I Ltd DATE OF NAME CHANGE: 20140709 8-K 1 mdt-20240523.htm 8-K mdt-20240523 0001613103 Medtronic plc D02 XH02 false 0001613103 2024-05-23 2024-05-23 0001613103 us-gaap:CommonStockMember 2024-05-23 2024-05-23 0001613103 mdt:SeniorNotes2019Due2025Member 2024-05-23 2024-05-23 0001613103 mdt:SeniorNotes2020Due2025Member 2024-05-23 2024-05-23 0001613103 mdt:SeniorNotesDue2025Member 2024-05-23 2024-05-23 0001613103 mdt:SeniorNotes2019Due2027Member 2024-05-23 2024-05-23 0001613103 mdt:SeniorNotes2020Due2028Member 2024-05-23 2024-05-23 0001613103 mdt:SeniorNotesDue2028Member 2024-05-23 2024-05-23 0001613103 mdt:SeniorNotes2019Due20311.625PercentMember 2024-05-23 2024-05-23 0001613103 mdt:SeniorNotes2019Due20311.00PercentMember 2024-05-23 2024-05-23 0001613103 mdt:SeniorNotesDue2031Member 2024-05-23 2024-05-23 0001613103 mdt:SeniorNotes2020Due2032Member 2024-05-23 2024-05-23 0001613103 mdt:SeniorNotesDue2034Member 2024-05-23 2024-05-23 0001613103 mdt:SeniorNotes2019Due20392.250PercentMember 2024-05-23 2024-05-23 0001613103 mdt:SeniorNotes2019Due20391.50PercentMember 2024-05-23 2024-05-23 0001613103 mdt:SeniorNotes2020Due2040Member 2024-05-23 2024-05-23 0001613103 mdt:SeniorNotes2019Due2049Member 2024-05-23 2024-05-23 0001613103 mdt:SeniorNotes2020Due2050Member 2024-05-23 2024-05-23 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   _____________________________  FORM 8-K   _____________________________  CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 23, 2024   _____________________________  Medtronic plc (Exact name of Registrant as Specified in its Charter)    _____________________________    Ireland   1-36820   98-1183488 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.) 20 On Hatch, Lower Hatch Street Dublin 2 , Ireland (Address of principal executive offices) (Zip Code) + 353 1 438-1700 (Registrant’s telephone number, including area code) Not Applicable Former name or former address, if changed since last report Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities r

View on Read The Filing